Nemaura Medical Inc. (NMRD) |
|
0.315 -0.031 (-8.96%)
|
09-29 15:59 |
|
Open: |
0.35 |
Pre. Close: |
0.346 |
|
High:
|
0.3543 |
Low:
|
0.3 |
|
Volume:
|
179,366 |
Market Cap:
|
9(M) |
|
|
|
Technical analysis |
as of: 2023-10-02 8:19:06 AM |
|
Short-term rate:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
|
Mid-term rate:
|
|
| Target: |
Six months: 0.56 One year: 0.69 |
| Support: |
Support1: 0.3 Support2: 0.24 |
| Resistance: |
Resistance1: 0.47 Resistance2: 0.59 |
| Pivot: |
0.38 |
| Moving Average: |
MA(5): 0.34 MA(20): 0.39
MA(100): 0.67 MA(250): 1.22 |
| MACD: |
MACD(12,26): -0.1  Signal(9): -0.1 |
| Stochastic oscillator: |
%K(14,3): 4.2 %D(3): 3.2 |
| RSI: |
RSI(14): 29.2 |
| 52-week: |
High: 3.43 Low: 0.3 |
| Average Vol(K): |
3-Month: 228 (K) 10-Days: 177 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ NMRD ] has closed above bottom band by 6.9%. Bollinger Bands are 53.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.35 - 0.36 |
0.36 - 0.36 |
|
Low:
|
0.3 - 0.3 |
0.3 - 0.3 |
|
Close:
|
0.32 - 0.32 |
0.32 - 0.33 |
|
Company Description |
|
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York. |
Headline News |
Tue, 26 Sep 2023
Nemaura Medical Announces Appointment of Mr Nikolai Rozanov as Strategic Adviser in Artificial Intelligence, to Assist in Development of its AI Health Coach, and Strengthen Outcomes in its CGM Based Metabolic and Type 2 Diabetes Programs. - Yahoo Finance
Mon, 18 Sep 2023
Wearable Devices and IoT Revolutionize Healthcare Monitoring and ... - PR Newswire
Mon, 18 Sep 2023
Nemaura Medical to Present at the Maxim Group Emerging Growth ... - GlobeNewswire
Fri, 15 Sep 2023
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and ... - InvestorPlace
Thu, 14 Sep 2023
Top Penny Stock Gainers Momentum Watchlist (ORHB, GSAC, NMRD, SASI) - Duos Technologies Group (NASDAQ:DUO - Benzinga
Thu, 14 Sep 2023
Nemaura Medical Provides Update on Nasdaq Compliance Status and Process - Yahoo Finance
|
Financial Analysis |
| Price to Book Value: |
Underperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Outperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Underperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
0 (M) |
| Shares Float |
29 (M) |
|
% Held by Insiders
|
1.246e+007 (%) |
|
% Held by Institutions
|
49 (%) |
|
Shares Short
|
43 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
-8.63e+006 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-11 |
|
Return on Assets (ttm)
|
780.4 |
|
Return on Equity (ttm)
|
-40.3 |
|
Qtrly Rev. Growth
|
77040 |
|
Gross Profit (p.s.)
|
0 |
|
Sales Per Share
|
0 |
|
EBITDA (p.s.)
|
-4.35294e+006 |
|
Qtrly Earnings Growth
|
-0.5 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
-9 (M) |
Stock Valuations |
|
PE Ratio
|
-0.01 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0 |
|
Price to Sales
|
0 |
|
Price to Cash Flow
|
-0.22 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
273250 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
